Effects of valsartan on the progression of renal and cardiovascular disease - Kanagawa Valsartan Trial (KVT)
Phase of Trial: Phase IV
Latest Information Update: 03 Apr 2015
At a glance
- Drugs Valsartan (Primary) ; ACE inhibitors; Beta-adrenergic receptor antagonists; Calcium channel antagonists; Diuretics
- Indications Cardiovascular disorders; Hypertension; Kidney disorders
- Focus Therapeutic Use
- Acronyms KVT
- 24 Mar 2009 Actual patient number (312) added, actual end date (Apr 2008) added, additional lead trial centre/investigator identified as reported by ClinicalTrials.gov.
- 24 Mar 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 11 Nov 2005 New trial record.